Extended Research Article
Cyclooxygenase-2 selective non-steroidal anti-inflammatory (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis or rheumatoid arthritis: a systematic review and economic evaluation
Chen Y-F
,
Jobanputra P
,
Barton P
,
Bryan S
,
Fry-Smith A
,
et al.
-
Journal:
Health Technology Assessment Volume: 12, Issue: 11
-
Published:
16 April 2008